Related Experiment Video
Updated: Jun 5, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
[Introduction to adverse drug reactions and drug-drug interaction]
1Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik, Universitätsklinikum Heidelberg. gerd.mikus@med.uni-heidelberg.de
Abstract:
Adverse drug reactions are very common during a systemic drug therapy. Most of these are fortunately mild or moderate and transient. Serious adverse drug reactions often lead to hospitalisation. Drug-drug interactions can also contribute substantially to differences in drug response. Drug-induced inhibition of drug metabolising enzymes is usually competitive and causes an increased exposure of the drug whose metabolism is inhibited. This usually results in a higher incidence of adverse drug reactions and an increased severity. Conversely enzyme induction increases the metabolic capacity thereby reducing the exposure of a drug with sometimes loss of drug effects (nonresponse). Detailed knowledge of the causative mechanisms will help detecting and avoiding severe adverse drug reactions.
Related Concept Videos
Drug toxicity: Drug–Drug Interaction
Pharmacokinetics: Drug–Drug Interactions
Drug Toxicity: Overview
Drug Toxicity: Risk factors
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...

